GVHD in the era of checkpoint inhibition in Hodgkin Lymphoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cecilia Anna,Fidanza

第一单位： Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

作者： Cecilia Anna,Fidanza ^[1] ; Fabio,Serpenti ^[2] ; Francesca,Cavallaro ^[3] ; Kordelia,Barbullushi ^[3] ; Nicolò,Rampi ^[3] ; Francesca Gaia,Rossi Dardanoni ^[4] ; Maria Cecilia,Goldaniga ^[4] ; Giorgia Natascia,Saporiti ^[5] ; Francesco,Passamonti ^[6]

作者单位： Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. ^[1] Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy. ^[2] Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. ^[3] FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILANO, Italy. ^[4] Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, MILANO, Italy. ^[5] Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy, Italy. ^[6]

DOI 10.1182/bloodadvances.2025015912

PMID 39913922

发布时间 2025-02-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood advances

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

GVHD in the era of checkpoint inhibition in Hodgkin Lymphoma.

Blood advances

相似文献

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

GVHD in the era of checkpoint inhibition in Hodgkin Lymphoma.

Blood advances

相似文献

Blood advances

相关期刊

检索历史清除